Cohort Study: Polypharmacy, potentially inappropriate medications, and drug-drug interactions in vulnerable older adults with advanced cancer initiating cancer treatment.

Polypharmacy, Potentially Inappropriate Medications, and Drug-Drug Interactions in Vulnerable Older Adults With Advanced Cancer Initiating Cancer Treatment – The Oncologist

Commentaries:

Polypharmacy can lead to harmful drug interactions, especially among cancer patients – News Medical

Analysis Underscores Risks of Polypharmacy in Elderly Patients With Cancer – AJMC

Commentary on Twitter

Our new article in @OncJournal : In a large cohort of older adults with advanced cancer, polypharmacy &PIM are very common. Nonprescription meds are frequently PIMs &involved in potential harmful drug interactions @WilmotCancer @rochgerionc @myCARGhttps://t.co/bA7W4kyybm pic.twitter.com/zFI3EgS320

— Mostafa R Mohamed (@m_refaat84) April 2, 2022

Under a https://creativecommons.org/licenses/by/4.0/ license